Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Raw Materials (2016 - 2025)

InspireMD (NSPR) has 13 years of Raw Materials data on record, last reported at $2.3 million in Q3 2025.

  • For Q3 2025, Raw Materials rose 26.26% year-over-year to $2.3 million; the TTM value through Sep 2025 reached $2.3 million, up 26.26%, while the annual FY2024 figure was $1.9 million, 43.48% up from the prior year.
  • Raw Materials reached $2.3 million in Q3 2025 per NSPR's latest filing, up from $2.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $2.3 million in Q3 2025 and bottomed at $581000.0 in Q3 2021.
  • Average Raw Materials over 5 years is $1.2 million, with a median of $965500.0 recorded in 2022.
  • Peak YoY movement for Raw Materials: dropped 26.64% in 2021, then skyrocketed 78.26% in 2024.
  • A 5-year view of Raw Materials shows it stood at $615000.0 in 2021, then soared by 51.54% to $932000.0 in 2022, then surged by 43.13% to $1.3 million in 2023, then skyrocketed by 43.48% to $1.9 million in 2024, then grew by 20.06% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $2.3 million in Q3 2025, $2.2 million in Q2 2025, and $1.9 million in Q1 2025.